How physiologically based pharmacokinetic models should be improved for drug development

被引：1
|
作者：
Hempel, Georg [1 ]
机构：
[1] Westfal Wilheims Univ Munster, Inst Pharmazeut & Med Chem, Klin Pharm, Corrensstr 48, D-48149 Munster, Germany
来源：
FUTURE MEDICINAL CHEMISTRY | 2020年 / 12卷 / 12期
关键词：
antimicrobial drugs; drug development; drug metabolism; infectious disease therapeutics; pharmacokinetics/pharmacodynamics; pharmacology; systems biology; A-PRIORI; KINETICS;
D O I：
10.4155/fmc-2020-0074
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
[No abstract available]
引用
收藏
页码：1107 / 1109
页数：3
相关论文
共 50 条
  • [21] Drug dosing during pregnancy-opportunities for physiologically based pharmacokinetic models
    Abduljalil, Khaled
    Badhan, Raj K. Singh
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2020, 47 (04) : 319 - 340
  • [22] Clinical Pharmacokinetic/Pharmacodynamic and Physiologically based Pharmacokinetic Modeling in New Drug Development: The Capecitabine Experience
    Karen S. Blesch
    Ronald Gieschke
    Yuko Tsukamoto
    Bruno G. Reigner
    Hans U. Burger
    Jean-Louis Steimer
    Investigational New Drugs, 2003, 21 : 195 - 223
  • [23] Clinical pharmacokinetic/pharmacodynamic and physiologically based pharmacokinetic modeling in new drug development: The capecitabine experience
    Blesch, KS
    Gieschke, R
    Tsukamoto, Y
    Reigner, BG
    Burger, HU
    Steimer, JL
    INVESTIGATIONAL NEW DRUGS, 2003, 21 (02) : 195 - 223
  • [24] Development and evaluation of physiologically based pharmacokinetic drug-disease models for predicting captopril pharmacokinetics in chronic diseases
    Muhammad F. Rasool
    Shazia Ali
    Sundus Khalid
    Ramsha Khalid
    Abdul Majeed
    Imran Imran
    Hamid Saeed
    Muhammad Usman
    Mohsin Ali
    Amer S. Alali
    Abdullah F. AlAsmari
    Nemat Ali
    Ali Mohammed Asiri
    Fawaz Alasmari
    Faleh Alqahtani
    Scientific Reports, 11
  • [25] Development and evaluation of physiologically based pharmacokinetic drug-disease models for predicting captopril pharmacokinetics in chronic diseases
    Rasool, Muhammad F.
    Ali, Shazia
    Khalid, Sundus
    Khalid, Ramsha
    Majeed, Abdul
    Imran, Imran
    Saeed, Hamid
    Usman, Muhammad
    Ali, Mohsin
    Alali, Amer S.
    AlAsmari, Abdullah F.
    Ali, Nemat
    Asiri, Ali Mohammed
    Alasmari, Fawaz
    Alqahtani, Faleh
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [26] DEVELOPMENT OF PHYSIOLOGICALLY-BASED PHARMACOKINETIC AND PHYSIOLOGICALLY-BASED PHARMACODYNAMIC MODELS FOR APPLICATIONS IN TOXICOLOGY AND RISK ASSESSMENT
    ANDERSEN, ME
    TOXICOLOGY LETTERS, 1995, 79 (1-3) : 35 - 44
  • [27] CLEARANCE CONSTANTS IN PHYSIOLOGICALLY BASED PHARMACOKINETIC MODELS
    CHEN, HSG
    GROSS, JF
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1979, 68 (08) : 1066 - 1067
  • [28] The rapid generation of physiologically based pharmacokinetic models
    Loizou, G
    Spendiff, M
    Hogg, A
    Pryde, E
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2004, 197 (03) : 366 - 367
  • [29] Structural identifiability of physiologically based pharmacokinetic models
    Yates, JWT
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2006, 33 (04) : 421 - 439
  • [30] Physiologically Based Pharmacokinetic (PBPK) Models for Ethanol
    Plawecki, Martin H.
    Han, Jae-Joon
    Doerschuk, Peter C.
    Ramchandani, Vijay A.
    O'Connor, Sean J.
    IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING, 2008, 55 (12) : 2691 - 2700
12345